CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Current Assets:
Cash and cash equivalents	$ 10,982	$ 14,546
Marketable debt securities	1,948	1,285
Receivables	8,660	8,501
Inventories	1,953	2,074
Other current assets	3,568	3,786
Total current assets	27,111	30,192
Property, plant and equipment	5,763	5,886
Goodwill	20,524	20,547
Other intangible assets	50,819	53,243
Deferred income taxes	793	1,161
Marketable debt securities	288	433
Other non-current assets	7,137	7,019
Total Assets	112,435	118,481
Current Liabilities:
Short-term debt obligations	1,777	2,340
Accounts payable	2,972	2,713
Other current liabilities	12,581	14,027
Total Current Liabilities	17,330	19,080
Deferred income taxes	5,235	5,407
Long-term debt	44,505	48,336
Other non-current liabilities	7,692	7,776
Total Liabilities	74,762	80,599
Bristol-Myers Squibb Company Shareholders' Equity:
Preferred stock	0	0
Common stock	292	292
Capital in excess of par value of stock	43,852	44,325
Accumulated other comprehensive loss	(1,544)	(1,839)
Retained earnings	22,204	21,281
Less cost of treasury stock	(27,199)	(26,237)
Total Bristol-Myers Squibb Company Shareholders' Equity	37,605	37,822
Noncontrolling Interest	68	60
Total Equity	37,673	37,882
Total Liabilities and Equity	$ 112,435	$ 118,481